drugset / Trial / NCT01642134

Dual Antiplatelet Therapy Versus Oral Anticoagulation for a Short Time to Prevent Cerebral Embolism After TAVI

NCT01642134 ↗

Phase 4 Completed 124 enrolled Andres Iñiguez Romo, MD, PhD
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to determine the incidence of major vascular events (ischemic or haemorrhagics) at the third month after initiation of the antithrombotic treatment (oral anticoagulation or dual antiplatelet therapy) in both arms followed TAVI.

Timeline

Start
2013-04
Primary completion
2019-06-30
Completion
2019-06-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Aspirin Small molecule 100 mg —
Comparator Clopidogrel Small molecule 75 mg —